5AM Ventures, located in Menlo Park, California, was founded in 2002 by John Diekman. The venture fund focuses on BioTech, Life Science, Healthcare, Advanced Materials, Consumer Electronics, Hardware, Industrials, Manufacturing, PropTech, and IoT sectors, financing companies at Pre-Seed to Series D stages. With 166 investments and 42 exits, 5AM Ventures actively supports portfolio companies like Artiva Biotherapeutics, Enliven Therapeutics, Dianthus Therapeutics, and Halio. The fund's primary goal is to invest in seed and early-stage life sciences companies. For more information, visit their website at www.5amventures.com.